Prof. Suzanne Pasmans and Dr. Joan Totte of the Erasmus Medical Centre are are working on a clincal trial to find how endolysin can treat eczema suffers. The trial will involve 100 patients being given either the endolysin or a placebo.
The aim of the trial is to quantify the reduction of the bacteria on the skin and how it relates to the severity of the eczema symptons and how this affects the patients use of corticosteriods.
The results of this trial will not be know for until the end of the year, but should given an indication of how important a role Staphylococcus aureus plays in eczema.
|Gladskin Eczema Gel 30ml – relieves itch and redness and prevents inflammation|